Plastic surgeon Gaurav Bharti, MD, FACS, and Cytrellis Biosystems CEO Denise Dajles, D.Eng, share clinical and strategic insights into how ellacor is changing the way skin laxity and facial wrinkles are treated without surgery or thermal energy.
Guidepoint Qsight’s Erik Haines breaks down the drivers behind 2024’s $17.5 billion in non-surgical aesthetic spending and what it signals for the future of the industry.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.
The investment will help scale the company’s 2910 nm fiber laser platforms, designed for use across all skin types.
While known for cosmetic procedures, Raghu Athré also provides reconstructive care to patients facing medical and financial hardship.
